摘要
癌症是一种涉及不受控制的细胞分裂的多因素健康状况。这种疾病的根源在于基因突变。这种疾病影响男性、女性甚至儿童。化学疗法、光动力、光热和激素疗法已被用于治疗这种最致命的疾病,但很大一部分患者有疾病复发或抵抗的机会。如今,miRNAs的失调被认为是不同类型癌症发生和发展的关键因素之一,因为它们控制着负责细胞增殖、生长、分化和凋亡的基因的表达。具有抗癌特性的膳食植物化学物质已成为癌症治疗的焦点,因为它们被发现通过调节 miRNA 表达在靶向癌症方面更有效。这些植物化学物质没有副作用,并且很容易以低成本获得。已经报道了几种对 miRNA 表达具有调节作用的膳食植物化学物质,包括姜黄素、二烯丙基二硫化物、3, 30-二吲哚甲烷、鞣花酸、染料木黄酮、吲哚-3-甲醇、槲皮素、白藜芦醇和萝卜硫素。它们通过上调或下调不同的癌症信号通路并抑制其进展来发挥对不同癌症的调节作用。姜黄素下调 SHH 通路,epigallocatechin-3-gallate 调节 Notch 通路并抑制 TGFβ1/SMAD 信号通路,白藜芦醇通过 JAK2/STAT3 信号通路调节 Wnt/β-catenin 通路和鼠尾草酸诱导的结肠癌细胞凋亡。 miRNA作为细胞途径中的重要调节剂用于治疗癌症。因此,识别miRNA及其靶标并用特定的植物化学物质对抗它们为治疗癌症提供了一种安全有效的机制。
关键词: 癌症、植物化学物质、miRNA、信号通路、膳食植物化学物质、靶标。
Current Medicinal Chemistry
Title:Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting
Volume: 28 Issue: 39
关键词: 癌症、植物化学物质、miRNA、信号通路、膳食植物化学物质、靶标。
摘要: Cancer is a multi-factorial health condition involving uncontrolled cell divisions. The disease has its roots in genetic mutation. This disease affects men, women, and even children. Chemotherapy, photodynamic, photothermal, and hormonal therapies have been used to treat this deadliest disease, but a huge percentage of patients have chances of disease recurrence or resistance. Nowadays, dysregulation in miRNAs is considered one of the key factors for the development and progression of different types of cancers as they control the expression of genes responsible for cell proliferation, growth, differentiation, and apoptosis. Dietary phytochemicals with anticancer properties have been gaining focus for cancer treatment since they have been found more effective in targeting cancer via regulating miRNAs expression. These phytochemicals have no side effects and are readily available at a low cost. Several dietary phytochemicals with regulatory effects on the expression of miRNAs have been reported, including curcumin, diallyl disulfide, 3, 30-diindolylmethane, ellagic acid, genistein, indole-3-carbinol, quercetin, resveratrol, and sulforaphane. They exert their regulatory effects against different cancers either by upregulating or downregulating different cancer signalling pathways and inhibiting their progression. Curcumin down-regulates SHH pathways, epigallocatechin-3-gallate regulates the Notch pathway and inhibits TGFβ1/SMAD signalling, and resveratrol regulates the Wnt/β-catenin pathway and carnosic acid-induced apoptosis in colon cancer cell via JAK2/STAT3 signalling pathway. The miRNAs are used for the treatment of cancer as essential modulators in cellular pathways. Therefore, identifying the miRNAs and their targets and countering them with specific phytochemicals provide a safe and effective mechanism for the treatment of cancer.
Export Options
About this article
Cite this article as:
Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867328666210420101605
DOI https://dx.doi.org/10.2174/0929867328666210420101605 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Protease Inhibitors in the Clinic
Medicinal Chemistry Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Enantiomeric Local Anesthetics: Can Ropivacaine and Levobupivacaine Improve Our Practice?
Current Drug Therapy Glibenclamide Action on Myocardial Function and Arrhythmia Incidence in the Healthy and Diabetic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications
Current Drug Targets Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
Current Pharmaceutical Design Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cosignaling Molecules Around LIGHT-HVEM-BTLA: From Immune Activation to Therapeutic Targeting
Current Molecular Medicine Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
CNS & Neurological Disorders - Drug Targets Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Current Topics in Medicinal Chemistry Potential Application of 5-Aryl-Substituted 2-Aminobenzamide Type of HDAC1/2- Selective Inhibitors to Pharmaceuticals
Current Pharmaceutical Design Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Targeting Adhesion Molecules in Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Estrogen Regulation of MicroRNA Expression
Current Genomics Nutrient Regulation of Tumor and Vascular Endothelial Cell Proliferation
Current Cancer Drug Targets The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
Current Pharmaceutical Design The Role of Wnt/Beta-Catenin Signaling in Renal Carcinogenesis: Lessons from Cadmium Toxicity Studies
Current Molecular Medicine